Entero Therapeutics, Inc. (ENTO) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 36.25K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 35.6K | 12.29K | 7.32K | 23.41K | 23.13K | 22.85K |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | -35.6K | -12.29K | -7.32K | -23.41K | -23.13K | -22.85K |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | 100% | 100% | 100% | 100% | -53.93% | 46.19% | 67.58% | -5.05% | 24.97% | 25.11% |
| Operating Expenses | 4.03M | 934.79K | 638.86K | 821.39K | 1.2M | 1.89M | 3.39M | 9.23M | 4.09M | 3.43M | 4.18M | 4.06M |
| OpEx % of Revenue | 11119.61% | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 3.14M | 928.11K | 628.23K | 805.56K | 1.18M | 1.69M | 3.17M | 8.66M | 2.79M | 2.42M | 2.83M | 2.7M |
| SG&A % of Revenue | 8658.02% | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 892.35K | 6.67K | 10.63K | 15.83K | 21.42K | 207K | 219.59K | 565.96K | 1.31M | 1.01M | 1.35M | 1.36M |
| R&D % of Revenue | 2461.59% | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -653 | -495 | 0 | -2.62K | -1.11K |
| Operating Income | -4.69M | -934.79K | -638.86K | -821.39K | -1.2M | -1.89M | -3.43M | -9.23M | -4.09M | -3.43M | -4.18M | -4.06M |
| Operating Margin % | -12933.16% | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -289.56% | 50.61% | 81.35% | 91.1% | 70.6% | 44.87% | 18.07% | -127.1% | -179470.69% | -78311.95% | -77254.01% | -43199.87% |
| EBITDA | -4.69M | -934.79K | -638.86K | -930.2K | -1.2M | -1.89M | -3.39M | -9.21M | -4.09M | -3.43M | -4.17M | -4.06M |
| EBITDA Margin % | -12933.16% | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -289.56% | 50.57% | 81.16% | 89.9% | 70.55% | 44.79% | 18.77% | -127.2% | -179726.9% | -78015.34% | -77223.29% | -43155.61% |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 0 | 0 | 1.34K | 35.32K | 12.29K | 7.32K | 7.32K | 7.32K | 7.32K |
| EBIT | 0 | -934.79K | -638.86K | -930.2K | -1.2M | -1.89M | -3.43M | -9.23M | -4.09M | -3.43M | -4.18M | -4.06M |
| Net Interest Income | 0 | -36.07K | -36.07K | -17.9K | 200 | 229 | 218 | -65.97K | -6.82K | -1.02K | -4.97K | -7.11K |
| Interest Income | 0 | 0 | 0 | 0 | 200 | 229 | 218 | 228 | 224 | 229 | 205 | 1.87K |
| Interest Expense | -400.8K | 36.07K | 36.07K | 17.9K | 0 | 0 | 0 | 66.2K | 7.05K | 1.25K | 5.18K | 8.99K |
| Other Income/Expense | 728.72K | -36.07K | -36.07K | -126.72K | 9.44K | -2.65K | -4.11K | -66.63K | -7.32K | -1.02K | -7.59K | -8.23K |
| Pretax Income | -3.96M | -970.86K | -674.93K | -948.11K | -1.19M | -1.9M | -3.43M | -9.29M | -4.1M | -3.43M | -4.19M | -4.07M |
| Pretax Margin % | -10922.97% | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 10.6M | 0 | 4.26M | -14.86M | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | -888.11% | 0% | -124.05% | 159.92% | 0% | 0% | 0% | 0% |
| Net Income | -3.14M | -1.15M | -998.27K | -1.26M | -12.24M | -2.58M | -8.81M | 5.57M | -4.1M | -3.43M | -4.19M | -4.07M |
| Net Margin % | -8669.77% | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 74.32% | 55.33% | 88.67% | -122.62% | -198.43% | 24.84% | -110.25% | 236.77% | -2.88% | -178.2% | 22.54% | 57.72% |
| Net Income (Continuing) | -3.96M | -970.86K | -674.93K | -948.11K | -11.8M | -1.9M | -7.69M | 5.57M | -4.1M | -3.43M | -4.19M | -4.07M |
| Discontinued Operations | 0 | -181.95K | -323.34K | -311.51K | -439.56K | -685.72K | -1000K | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 5.13M | 5.29M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -2.92 | -0.75 | -0.21 | -0.28 | -2.57 | -0.57 | -3.84 | 4.23 | -11.48 | -9.08 | -36.89 | -35.70 |
| EPS Growth % | -13.62% | -31.58% | 94.53% | -106.62% | 77.61% | 93.72% | 89.59% | 111.85% | 85.67% | -102.49% | 96.46% | 98.63% |
| EPS (Basic) | -2.92 | -0.75 | -0.21 | -0.28 | -2.57 | -0.57 | -3.84 | 3.12 | -11.48 | -9.08 | -36.89 | -35.70 |
| Diluted Shares Outstanding | 1.62M | 1.65M | 4.76M | 4.77M | 4.75M | 4.55M | 2.29M | 1.32M | 357.32K | 378.3K | 113.55K | 114.03K |
| Basic Shares Outstanding | 1.62M | 1.65M | 4.76M | 4.77M | 4.75M | 4.55M | 2.29M | 1.76M | 357.32K | 378.3K | 113.55K | 114.03K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |